NEPH — NEPHROS INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1196298 ·
Last close
$4.41
Market Cap
$47.89M
52W High
$4.87
52W Low
$3.10
ADV30
24,276
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 5,212,000 | 2,993,000 | 97,000 | 140,000 | 13,794,000 | 4,018,000 | 3,093,000 |
| Dec 2025 | 4,729,000 | 2,761,000 | 18,000 | 62,000 | 13,641,000 | 5,400,000 | 3,439,000 |
| Sep 2025 | 4,764,000 | 2,915,000 | 314,000 | 337,000 | 13,247,000 | 5,171,000 | 3,241,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-348,000
Investing CF
$0
Financing CF
$285,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.17
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-142,998,000
Inventory
$3,619,000
Receivables
$3,521,000
ST Investments
—
EBIT TTM
$746,000
Pretax Income TTM
$788,000
Interest Exp TTM
$1,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$20,722,000
EBITDA
$1,763,000
Free Cash Flow
$-1,451,375
Enterprise Value
$44,068,128
Total Cash
$4,697,000
Total Debt
$872,000
Shares Out
10,860,120
Trailing EPS
$0.18
Book Value
$1.10
ROE
16.1%
ROA
7.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 18,789,000 | 1,146,000 | 1,194,000 | 13,641,000 | 3,439,000 | — | 1,645,000 |
| Dec 2024 | 14,162,000 | 6,000 | 74,000 | 11,210,000 | 2,625,000 | — | -492,000 |
| Dec 2023 | 14,238,000 | -1,593,000 | -1,575,000 | 11,861,000 | 3,503,000 | — | 827,000 |
| Dec 2022 | 9,975,000 | -4,335,000 | -7,382,000 | 10,999,000 | 2,118,000 | — | -3,234,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.21
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| QTI | QT IMAGING HOLDINGS, INC. | $48.45M | $3.31 | — |
| POCI | PRECISION OPTICS CORPORATION, INC. | $48.54M | $4.43 | — |
| AURX | Nuo Therapeutics, Inc. | $49.89M | $1.03 | — |
| XTNT | Xtant Medical Holdings, Inc. | $45.28M | $0.32 | — |
| VASO | VASO Corp | $51.05M | $0.29 | — |
News headlines (Yahoo Finance, 1h cache)
Nephros (NEPH) Q2 2026 Earnings Call Transcript
2026-08-13 11:42 · Yahoo
Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge ...
2026-08-07 05:11 · Yahoo
Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026
2026-08-06 20:10 · Yahoo
Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET
2026-07-20 11:00 · Yahoo
Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water
2026-06-16 11:00 · Yahoo
Nephros Announces Financial Results for Quarter Ended March 31, 2026
2026-05-07 20:05 · Yahoo
Nephros Schedules First Quarter 2026 Financial Results Conference Call
2026-04-30 20:00 · Yahoo
Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise
2026-04-01 13:00 · Yahoo
Nephros, Inc. Q2 2026 Earnings Call Summary
2026-08-07 12:30 · Yahoo
Nephros Schedules Second Quarter 2026 Financial Results Conference Call
2026-08-05 20:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.